AMS企画株式会社

2 known investors

AMS develops next-generation nuclear medicine technologies for Japan's market, including PET diagnostics and radiotherapeutics for precision oncology, alongside a proprietary bedside filtration system for safe radioactive waste management in hospitals.

BiotechHealthtechMedical Devices